These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 27374091)
21. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth. Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777 [TBL] [Abstract][Full Text] [Related]
22. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis. Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630 [TBL] [Abstract][Full Text] [Related]
23. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma. Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514 [TBL] [Abstract][Full Text] [Related]
24. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766 [TBL] [Abstract][Full Text] [Related]
25. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275 [TBL] [Abstract][Full Text] [Related]
26. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Fang J; Zhou Q; Liu LZ; Xia C; Hu X; Shi X; Jiang BH Carcinogenesis; 2007 Apr; 28(4):858-64. PubMed ID: 17071632 [TBL] [Abstract][Full Text] [Related]
27. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ; Bellamy WT; Briehl MM; Powis G Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766 [TBL] [Abstract][Full Text] [Related]
28. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells. Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445 [TBL] [Abstract][Full Text] [Related]
29. Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice. Chen C; Sun J; Liu G; Chen J Pathol Oncol Res; 2009 Mar; 15(1):109-14. PubMed ID: 18509748 [TBL] [Abstract][Full Text] [Related]
30. Antisense oligonucleotide of hypoxia-inducible factor-1alpha suppresses growth and tumorigenicity of lung cancer cells A549. Zhang W; Zhang H; Xing L J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):448-50. PubMed ID: 17120745 [TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A Oncotarget; 2016 Feb; 7(7):7816-28. PubMed ID: 26761211 [TBL] [Abstract][Full Text] [Related]
32. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells. Alqawi O; Moghaddas M; Singh G Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis. Bai X; Zhi X; Zhang Q; Liang F; Chen W; Liang C; Hu Q; Sun X; Zhuang Z; Liang T Cancer Lett; 2014 Dec; 355(2):281-7. PubMed ID: 25304380 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts. Zhang M; Chen C; Su F; Huang Z; Li X; Li X Technol Cancer Res Treat; 2017 Oct; 16(5):609-619. PubMed ID: 27573201 [TBL] [Abstract][Full Text] [Related]
35. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer. Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133 [TBL] [Abstract][Full Text] [Related]
36. Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation. Brossa A; Grange C; Mancuso L; Annaratone L; Satolli MA; Mazzone M; Camussi G; Bussolati B Oncotarget; 2015 May; 6(13):11295-309. PubMed ID: 25948774 [TBL] [Abstract][Full Text] [Related]
37. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. Kim TH; Hur EG; Kang SJ; Kim JA; Thapa D; Lee YM; Ku SK; Jung Y; Kwak MK Cancer Res; 2011 Mar; 71(6):2260-75. PubMed ID: 21278237 [TBL] [Abstract][Full Text] [Related]
38. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia]. Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037 [TBL] [Abstract][Full Text] [Related]
40. Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesis. Huang YC; Huang FI; Mehndiratta S; Lai SC; Liou JP; Yang CR Oncotarget; 2015 Jul; 6(21):18590-601. PubMed ID: 26087180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]